These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 3292151

  • 1. Dose-related effects of recombinant human erythropoietin on erythropoiesis. Results of a multicenter trial in patients with end-stage renal disease.
    Bommer J, Kugel M, Schoeppe W, Brunkhorst R, Samtleben W, Bramsiepe P, Scigalla P.
    Contrib Nephrol; 1988; 66():85-93. PubMed ID: 3292151
    [No Abstract] [Full Text] [Related]

  • 2. Analysis of initial resistance of erythropoiesis to treatment with recombinant human erythropoietin. Results of a multicenter trial in patients with end-stage renal disease.
    Kühn K, Nonnast-Daniel B, Grützmacher P, Grüner J, Pfåffl W, Baldamus CA, Scigalla P.
    Contrib Nephrol; 1988; 66():94-103. PubMed ID: 3292152
    [No Abstract] [Full Text] [Related]

  • 3. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial.
    Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW.
    N Engl J Med; 1987 Jan 08; 316(2):73-8. PubMed ID: 3537801
    [Abstract] [Full Text] [Related]

  • 4. Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials.
    Sobota JT.
    Contrib Nephrol; 1989 Jan 08; 76():166-78; discussion 212-8. PubMed ID: 2684519
    [No Abstract] [Full Text] [Related]

  • 5. The use of recombinant human erythropoietin (EPO) to correct the anemia of end-stage renal disease: a progress report.
    Adamson W, Egrie JC, Browne JK, Downing MR, Eschbach W.
    Behring Inst Mitt; 1988 Aug 08; (83):188-92. PubMed ID: 3071336
    [Abstract] [Full Text] [Related]

  • 6. Erythropoietin therapy in patients with chronic renal failure.
    Pinevich AJ, Petersen J.
    West J Med; 1992 Aug 08; 157(2):154-7. PubMed ID: 1441466
    [Abstract] [Full Text] [Related]

  • 7. Early intervention with recombinant human erythropoietin therapy.
    Teehan BP, Benz RL, Sigler MH, Brown JM.
    Semin Nephrol; 1990 Mar 08; 10(2 Suppl 1):28-34. PubMed ID: 2192414
    [No Abstract] [Full Text] [Related]

  • 8. Correction of anaemia in haemodialysis patients with recombinant human erythropoietin.
    Boran M, Dalva I, Yazicioğlu A, Akbay E, Cetin S.
    Int Urol Nephrol; 1993 Mar 08; 25(2):197-203. PubMed ID: 8365853
    [Abstract] [Full Text] [Related]

  • 9. Management of the anaemia of chronic renal failure with recombinant erythropoietin.
    Adamson JW, Eschbach JW.
    Q J Med; 1989 Dec 08; 73(272):1093-101. PubMed ID: 2694210
    [No Abstract] [Full Text] [Related]

  • 10. Investigating erythropoietin resistance.
    Koury MJ.
    N Engl J Med; 1993 Jan 21; 328(3):205-6. PubMed ID: 8417388
    [No Abstract] [Full Text] [Related]

  • 11. [The effect of recombinant human erythropoietin on erythrocyte lines in patients with anemia and chronic renal insufficiency].
    Marisavljević D, Djukanović Lj, Lezajić V.
    Srp Arh Celok Lek; 1992 Jan 21; 120(9-10):281-5. PubMed ID: 1306020
    [Abstract] [Full Text] [Related]

  • 12. Erythropoietin 1991--an overview.
    Eschbach JW.
    Am J Kidney Dis; 1991 Oct 21; 18(4 Suppl 1):3-9. PubMed ID: 1928076
    [Abstract] [Full Text] [Related]

  • 13. Treatment of the anaemia of end-stage renal disease with recombinant human erythropoietin.
    Verbeelen D, Hauglustaine D, Sennesael J.
    Neth J Med; 1988 Aug 21; 33(1-2):60-7. PubMed ID: 3247012
    [No Abstract] [Full Text] [Related]

  • 14. Quality of life: subjective and objective improvements with recombinant human erythropoietin therapy.
    Lundin AP.
    Semin Nephrol; 1989 Mar 21; 9(1 Suppl 1):22-9. PubMed ID: 2648517
    [Abstract] [Full Text] [Related]

  • 15. Treatment of anaemia of progressive renal failure with recombinant human erythropoietin. A preliminary report.
    Salim KA, Salim S, Mathew T.
    J Assoc Physicians India; 1992 Jan 21; 40(1):42-3. PubMed ID: 1634463
    [Abstract] [Full Text] [Related]

  • 16. Setting up an 'EPO' system. Management of patients receiving recombinant human erythropoietin.
    Brown SM.
    Prof Nurse; 1992 Feb 21; 7(5):282-3, 286-7. PubMed ID: 1738775
    [Abstract] [Full Text] [Related]

  • 17. Pediatric uses of recombinant human erythropoietin: the outlook in 1991.
    Alexander SR.
    Am J Kidney Dis; 1991 Oct 21; 18(4 Suppl 1):42-53. PubMed ID: 1928079
    [Abstract] [Full Text] [Related]

  • 18. [Anemia in acute renal failure and chronic renal failure].
    Koide K, Sano M, Takeda F, Morio K, Momose T.
    Nihon Rinsho; 1991 Mar 21; 49(3):685-9. PubMed ID: 2041197
    [No Abstract] [Full Text] [Related]

  • 19. [The recovery of erythropoiesis after the short-term Recormon treatment of renal anemia].
    Nikolaev AIu, Klepikov PV, Lashutin SV.
    Ter Arkh; 1992 Mar 21; 64(6):90-1. PubMed ID: 1440349
    [No Abstract] [Full Text] [Related]

  • 20. The clinical effects of recombinant human erythropoietin for the treatment of anemia in end stage renal disease patients on dialysis.
    Uthayanaka Y, Jirajan B, Krairithichai U, Jantavanich N.
    Southeast Asian J Trop Med Public Health; 1993 Sep 21; 24(3):577-82. PubMed ID: 8160072
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.